Navigation Links
Adeona's Planned Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrig's Disease is Hot Topic at 2011 California ALS Research Summit
Date:9/30/2011

dy. When motor neurons die, the ability of the brain to initiate and control muscle movement is lost. With voluntary muscle action progressively affected, patients in the later stages of the disease may become totally paralyzed. While non-invasive ventilation and gastrostomy tubes prolong life by 6-12 months, the average lifespan from time of symptom onset is 2-5 years. Currently, RILUTEK® is the only FDA-approved drug for ALS. RILUTEK is an NMDA receptor antagonist and has been shown to prolong life in patients with ALS by 3 months. Presently, there is no cure for ALS, nor is there a known cause. For more information on ALS, please visit the ALS Association website at www.alsa.org.

About the Ongoing Phase I/II Open Label Safety Study of Zinc Therapy in ALS Patients

Currently the clinical investigators at the PNA Center for Neurological Research are conducting a Phase I/II open label study of zinc therapy in ALS patients to determine the safety of zinc in conjunction with low doses of copper. To date, no safety issues related to zinc therapy have been observed in the ALS patients. For more information on this clinical study, please visit http://www.clinicaltrials.gov/ct2/show/NCT00919555.

About PNA Center for Neurological Research

PNA Center for Neurological Research (PNA) is an independent, not-for-profit organization based in Phoenix, Arizona. PNA was established by five of the neurologists from Phoenix Neurological Associates, Ltd., who are dedicated to discovering new treatments for patients with neurological diseases. The goal of PNA is to be a hub where philanthropists, advocates, organizations, family and friends of patients with a neurological illness could make donations that can support investigator-initiated clinical trials. PNA hopes to optimize proper treatments in order to improve outcomes for patients with
'/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
2. TargeGen Announces Planned Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients, and Presentations at ASH
3. Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig
4. Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
5. Celtic Pharma Announces Update on Status of XERECEPT(R) Program Sale Planned in 2009
6. Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound
7. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
8. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
9. Xanodyne Announces Planned President & CEO Succession
10. Breast Cancer Patient First in Latin America to Receive Treatment Using Elekta VMAT Planned with Monaco Software
11. Phase 3 Trial of Aflibercept in Second-Line Metastatic Colorectal Cancer to Continue as Planned at Recommendation of Independent Data Monitoring Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... By now, if you haven,t heard about the ALS Ice ... awareness campaign has brought this devastating disease to the forefront ... Million (and counting) for ALS. Every day, more and more ... as well. One such company, Acorn Stairlifts Inc., ... works with ALS sufferers and helps to provide solutions for ...
(Date:8/27/2014)... 27, 2014  Hill-Rom Holdings, Inc. (NYSE: ... presentation at the Morgan Stanley Global Healthcare Conference on ... You are invited to listen to the live discussion ... access it directly at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP .  A recorded ... after conclusion of the live event and accessible at ...
(Date:8/27/2014)... 2014 North American lighting leader OSRAM SYLVANIA ... for the new OSRAM ITOS ® PHASER ® ... for microscopy, endoscopy and surgical head lamps that delivers the ... and lamp life. "We,re honored to be recognized ... innovative new technologies of the past year," said Andreas ...
Breaking Medicine Technology:Acorn Stairlifts Gives a Lift to the ALS Ice Bucket Challenge 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3
(Date:8/27/2014)... All Canada Goose Parkas from CanadaGooseJackor.nu are great. ... modern. With unique detailing such as buttons, leather trim and ... up in opulence. Recently, the company has unveiled its new ... , True enough, the new assortment comes in various ... 28% off) on all these brand new items. By launching ...
(Date:8/27/2014)... Top 10 Best SEO Hosting, a well-known SEO Hosts Review ... iPage, Bluehost and GoDaddy are the most recommended suppliers for ... buy useful hosting (including VPS and cloud hosting). , ... has been serving hosting small business websites since 1998. With ... leader in the hosting industry for its affordable and easy ...
(Date:8/27/2014)... New Jersey’s own Morgan Hoffmann turned in ... during The Barclays – and thanks to finishing high ... four rounds, stepped his way into raising another $7,500 ... of New Jersey (Horizon BCBNSNJ) Walking Challenge. , Last ... before family and friends at the Paramus course, to ...
(Date:8/27/2014)... topical agents and light to kill tissue) appears to ... caused by sun damage) at three months after treatment ... , Author: Gayatri Patel, M.D., M.P.H., of ... and colleagues. , Background: AKs are rough, ... with fair complexions who have had lots of sun ...
(Date:8/27/2014)... Sound Telecom, a leading telecommunications company that offers ... systems, has unveiled an article titled “ Three Things ... .” The piece examines the world of medical messaging ... compliant with HIPAA and HITECH requirements. , Brian ... Sound Telecom, opens with evidence that the use of ...
Breaking Medicine News(10 mins):Health News:CanadaGooseJackor.nu: 2014 Canada Goose Banff Parkas At Discounted Prices 2Health News:Well-known SEO Hosts Review Site Top10BestSEOHosting.com Recommends iPage, Bluehost and GoDaddy To Webmasters 2Health News:Morgan Hoffmann, PGA TOUR Pro & Wyckoff Native, golfs and walks his way to top 10 finish at The Barclays while raising additional $7,500 for charity 2Health News:Photodynamic therapy vs. cryotherapy for actinic keratoses 2Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 2Health News:Sound Telecom Releases Article on Secure Messaging with Huge Implications for the Healthcare Industry 3
... ... Conference April 2010 , ... Orlando, FL (PRWEB) April 9, 2010 -- Distance learning services provider Compass Knowledge ... Dr. Fredrick Snow, and Dr. Larry Pawola, Clinical Associate Professor and Interim Head, ...
... passed the most comprehensive healthcare reform bill since the ... leaves much of the critical work of healthcare reform ... Wachter, Chief of the Division of Hospital Medicine, University ... Society of Hospital Medicine, in the April issue of ...
... ... of the 19th Annual Partnerships in Clinical Trials and located14th Annual eClinical Technology Summit, ... ... Data Management, a nonprofit association that supports data managers and others involved in clinical ...
... a substantial role in the surging number of autism diagnoses, ... of Sociology . The study, by researchers from the ... University, found that children living near a child who has ... of being diagnosed themselves in the following year. The increased ...
... ... Three-Month Report Outlines Next Steps , ... Port au Prince, Haiti (Vocus) April 8, 2010 -- Three months after a 7-magnitude ... , ,However, they still face a host of threats to their well-being, according to ...
... ... and reducing side effects , ... Santa Barbara, Calif. (Vocus) April 8, 2010 -- Researchers have shown that ... into tumor tissue. The peptide has been shown to substantially increase treatment efficacy against ...
Cached Medicine News:Health News:Compass Knowledge Group and University of Illinois at Chicago to Co-Present at UCEA National Conference April 2010 2Health News:Compass Knowledge Group and University of Illinois at Chicago to Co-Present at UCEA National Conference April 2010 3Health News:SCDM to Showcase Professional Development Opportunities at Partnerships Event 2Health News:Study: Social influence playing role in surging autism diagnoses 2Health News:Study: Social influence playing role in surging autism diagnoses 3Health News:Three Months after Haiti Quake, Life Still Perilous for Children 2Health News:Three Months after Haiti Quake, Life Still Perilous for Children 3Health News:Research Reveals Cancer Drug Effectiveness Substantially Advanced 2Health News:Research Reveals Cancer Drug Effectiveness Substantially Advanced 3Health News:Research Reveals Cancer Drug Effectiveness Substantially Advanced 4Health News:Research Reveals Cancer Drug Effectiveness Substantially Advanced 5
Puros allografts is a family of bone products specially designed and processed to meet the demanding needs of spine surgeons. The grafts are processed using the proprietary Tutoplast process....
... Graftech cervical dowels are ... to graft expulsion and improve ... allows immediate red blood cell ... Grafton DBM gel into the ...
8 mm S Graftech cervical spacer....
Lorenz 2.0 mm titanium system for the midface provides an excellent alternative to lower profile systems in areas of the midface where greater fixation is needed....
Medicine Products: